RGNX
RGNX
NASDAQ · Biotechnology

Regenxbio Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$8.03
+0.15 (+1.90%)
As of Sep 22, 2:46 PM ET ·
RGNX News1 articles
REGENXBIO Shares Tumble 37% Despite Duchenne Gene Therapy Trial Success
REGENXBIO (RGNX) stock plummeted 37% to $6.31 despite positive Phase III data for RGX-202, as two serious adverse events and FDA approval doubts overshadowed the results.
Technology